河南太龙药业股份有限公司2025年第三次临时股东大会决议公告

Meeting Overview - The third extraordinary general meeting of shareholders was held on August 15, 2025, at the company's conference room in Zhengzhou [2] - The meeting was convened by the board of directors and chaired by Chairman Yin Hui, using a combination of on-site and online voting [2][3] - All resolutions passed during the meeting were in compliance with the Company Law and the company's articles of association [2][5] Resolutions Passed - The proposal to abolish the supervisory board and amend the articles of association was approved [3] - Amendments to the rules of procedure for shareholder meetings, board meetings, and independent director work systems were also approved [4] - The election of the tenth board of directors, including both non-independent and independent directors, was conducted [4] Board of Directors Composition - The tenth board of directors consists of Chairman Wang Rongtao, Vice Chairman Li Jingliang, and other members including independent directors and a worker representative [30][31] - The board's term is set for three years, starting from the date of approval by the shareholders' meeting [31] Management Appointments - Li Jingliang was appointed as the General Manager, with other key appointments including Su Fengshan as Executive Vice General Manager and Zhao Hailin as Financial Officer [34] - The board secretary is Li Nianyun, and the securities affairs representative is Wu Ting, with all appointments aligned with the board's term [34][35] Legal Compliance - The meeting and its resolutions were witnessed by Henan Qianwen Law Firm, confirming that all procedures adhered to relevant laws and regulations [5][30]